Lynozyfic Prices, Coupons, Copay Cards & Patient Assistance
Lynozyfic (linvoseltamab) is a member of the bispecific T-cell engagers (BiTE) drug class and is commonly used for Multiple Myeloma.
Lynozyfic prices
Intravenous Solution
gcpt 2 mg/mL Lynozyfic intravenous solution from $467.00 for 2.5 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2.5 milliliters | $186.80 | $467.00 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
gcpt 20 mg/mL Lynozyfic intravenous solution from $18,371.74 for 10 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 10 milliliters | $1,837.17 | $18,371.74 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Lynozyfic Coupons, Copay Cards and Rebates
Lynozyfic offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Lynozyfic Surround Commercial Copay Program
Eligible commercially insured patients may pay as little as $0 and receive up to $25,000 in assistance per year.
- Applies to:
- Lynozyfic
- Number of uses:
- Per length of program
Form more information phone: 844-746-4363 or Visit website
Patient Assistance & Copay Programs for Lynozyfic
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Lynozyfic (linvoseltamab-gcpt) Injection; Solution
More information please phone: 800-675-8416 Visit website
Provider: LYNOZYFIC Surround
Eligibility requirements:- Must be uninsured or underinsured
- Not disclosed
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Co‑payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Lynozyfic (linvoseltamab-gcpt) Injection; Solution
More information please phone: 844-746-4363 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Lynozyfic (linvoseltamab)
- Check interactions
- Compare alternatives
- Dosage information
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- En español